Celgene Corp. (NASDAQ: CELG) and Merck (NYSE: MRK) are both top-flight biopharma stocks with significant footprints in the rapidly growing oncology market. But which is the better stock to buy right now? Let’s dig deeper to find out.
Image source: Getty Images.